Literature DB >> 14551691

[Altered cerebral excitability and spreading depression. Causes for the comorbidity of epilepsy and migraine?].

T Leniger1, H C Diener, A Hufnagel.   

Abstract

Increased co-occurrence and common clinical aspects of epilepsy and migraine lead to the question of a common pathophysiological model of the diseases. Shared genetic risk factors as an explanation for comorbidity could not be proven. Clinical studies underline the unspecific association of migraine and epilepsy. Comorbidity is based on spreading depression as an expression of altered brain state with neuronal hyperexcitability. In comorbid conditions, therapy with valproate, gabapentin, or topiramate may be effective.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551691     DOI: 10.1007/s00115-003-1538-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  46 in total

1.  Lamotrigine versus placebo in the prophylaxis of migraine with and without aura.

Authors:  T J Steiner; L J Findley; A W Yuen
Journal:  Cephalalgia       Date:  1997-04       Impact factor: 6.292

Review 2.  Migraine and the benign partial epilepsies of childhood: evidence for an association.

Authors:  F Andermann
Journal:  Epileptic Disord       Date:  2000       Impact factor: 1.819

3.  Lamotrigine in the prophylactic treatment of migraine aura--a pilot study.

Authors:  C Lampl; A Buzath; D Klinger; K Neumann
Journal:  Cephalalgia       Date:  1999-01       Impact factor: 6.292

4.  A gene for familial hemiplegic migraine maps to chromosome 19.

Authors:  A Joutel; M G Bousser; V Biousse; P Labauge; H Chabriat; A Nibbio; J Maciazek; B Meyer; M A Bach; J Weissenbach
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

5.  A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.

Authors:  Frederick G Freitag; S D Collins; H A Carlson; J Goldstein; J Saper; S Silberstein; N Mathew; P K Winner; R Deaton; K Sommerville
Journal:  Neurology       Date:  2002-06-11       Impact factor: 9.910

6.  Migraine-triggered epilepsy.

Authors:  E Niedermeyer
Journal:  Clin Electroencephalogr       Date:  1993-01

7.  Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.

Authors:  Ninan T Mathew; Jayasree Kailasam; Lori Meadors
Journal:  Headache       Date:  2002-09       Impact factor: 5.887

8.  Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysis.

Authors:  Randal L Von Seggern; Lisa K Mannix; James U Adelman
Journal:  Headache       Date:  2002-09       Impact factor: 5.887

9.  Neuroexcitatory plasma amino acids are elevated in migraine.

Authors:  M D Ferrari; J Odink; K D Bos; M J Malessy; G W Bruyn
Journal:  Neurology       Date:  1990-10       Impact factor: 9.910

Review 10.  A multivariate study of headache associated with ischemic stroke.

Authors:  J M Ferro; T P Melo; V Oliveira; A V Salgado; M Crespo; P Canhão; A N Pinto
Journal:  Headache       Date:  1995-06       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.